Quinapril and Hydrochlorothiazide 20/12.5 · QUINAPRIL HYDROCHLORIDE 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 · Tablet · Oral · Cipla USA Inc.
NDC 69097-0829-05 · 90 TABLET in 1 BOTTLE · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.4254 per unit over the past year.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cipla USA Inc. | QUINAPRIL HYDROCHLORIDE 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Cipla USA Inc. | QUINAPRIL HYDROCHLORIDE 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Cipla USA Inc. | HYDROCHLOROTHIAZIDE 12.5 mg/1; QUINAPRIL HYDROCHLORIDE 20 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Quinapril and Hydrochlorothiazide 20/12.5 — NDC 69097-0829-05," retrieved September 3, 2026, https://drugdashboards.com/drug/69097082905.
Free to cite with attribution — see how the data is put together.